MedTrace Logo

Improving Participation in Pulmonary Rehabilitation Through Peer Support and Storytelling

NCT05399056 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 305

Last updated 2025-12-12

No results posted yet for this study

Summary

Chronic Obstructive Pulmonary Disease (COPD) affects approximately 16 million Americans and is characterized by recurrent exacerbations that lead to 1.5 million Emergency Department visits and 700,000 hospitalizations annually. Pulmonary rehabilitation (PR) is a structured program of exercise and self-management support that has been proven to relieve shortness of breath and increase quality of life when initiated after an exacerbation, but unfortunately, few eligible patients participate. This project will compare the effectiveness of two novel strategies - one involving video narratives of other patients telling their story of how they overcame challenges and completed PR, the other involving telephonic peer coaching with an individual with lived experience - to enhanced usual care, and to each other, at increasing patient participation in PR after an exacerbation.

Conditions

Interventions

BEHAVIORAL

Telephonic Peer Coaching

Telephonic Peer Coaching from an individual with lived experience with COPD and Pulmonary Rehabilitation trained in motivational interviewing

BEHAVIORAL

Storytelling

Video narratives of an individual with lived experience with COPD and Pulmonary Rehabilitation describing their journey through Pulmonary Rehabilitation

Sponsors & Collaborators

  • University of Michigan

    collaborator OTHER

  • University of Massachusetts, Worcester

    collaborator OTHER

  • COPD Foundation

    collaborator OTHER

  • National Heart, Lung, and Blood Institute (NHLBI)

    collaborator NIH

  • Baystate Medical Center

    lead OTHER

Principal Investigators

  • Peter Lindenauer, MD, MSc · Baystate Health

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-02-24
Primary Completion
2026-02-28
Completion
2026-08-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05399056 on ClinicalTrials.gov